Biocare Medical is a leading developer of oncology focused immunohistochemistry (IHC) and in situ hybridisation (ISH) reagents for diagnosis and hromosomal profiling alongside an array of diagnostics instruments.
The Biocare portfolio of high-quality antibodies provides increased confidence for laboratory processes and critical diagnostics for patient therapies. The company’s core customers focus on clinical laboratories, bio-pharmaceutical companies and CRO’s.
GHO value creation
Enablement & Alignment
- Opportunity to create a global industry leader in IHC and ISH, servicing clinical labs and innovators in Pharma and Biotech
Capability & Capacity
- Enhanced investment and continued focus on product research and development as the business continues to target attractive adjacencies
- Development of further instrument lines driving significant market evolution to target underserved markets
Building Strategic Footprints
- Execution of organic and inorganic geographic expansion, in support of increasing global customer demand
Better, faster + more accessible healthcare
